2. Sliwka, H.R.; Melø, T.B.; Foss, B.J.; Abdel-Hafez, S.H.; Partali, V.; Nadolski, G.; Jackson,
H.; Lockwood, S.E. Chem. Eur. J. 2007, 13, 4458--4466.
3. Choi, S.K.; Osawa, A.; Maoka, T.; Hattan, J.; Ito, K.; Uchiyama, A.; Suzuki, M.; Shindo,
K.; Misawa, N.; Appl. Microbiol. Biotechnol. 2013, 97, 8479–8486.
4. Pfander, H., Hodler, M. Helv. Chim. Acta 1974, 57, 1641-1651.
5. Yamano, Y.; Sakai, Y.; Hara, M.; Ito, M. J. Chem. Soc., Perkin Trans. 1 2002, 2006-2013.
6. Yokoyama, A.; Shizuri, Y; Misawa, N. Tetrahedron Lett. 1998, 39, 3709-3712.
7. Nagy, V.; Agócs, A.; Turcsi, E.; Deli, J. Tetrahedron Lett. 2010, 51, 2020–2022.
8. Háda, M.; Nagy, V.; Deli, J.; Agócs, A.; Molecules 2012, 17, 5003-5012 (open access).
9. Schmidt, R.R.; Stump, M. Liebigs Ann. Chem. 1983, 7, 1249-1256.
10. Kildahl-Andersen, G.; Bruås, L.; Lutnaes, B. F. Org. Biomol. Chem. 2004, 2, 2496-2506.
Lutneas, B. J.; Kildahl-Andersen, G.; Krane, J.; Liaaen-Jensen, S. J. Am. Chem. Soc. 2004,
126, 8981–8990.
11. Synthesis of capsanthin glucosides: capsanthin (40 mg, 0.068 mM) was added to
trichloroacetimidate (350 mg, 0.71 mM) dissolved in dry CH2Cl2 (3 mL) at room temperature
under N2. After complete dissolution, dried p-TsOH (8 mg, 0.044 mM) was added. After
stirring for 6 h, trichloroacetimidate (175 mg, 0.35 mM) was added again to the solution
which was stirred overnight. When TLC showed complete conversion of capsanthin, the
mixture was diluted with Et2O (100 mL) and was washed with sat. NaHCO3 (40 mL) and
brine (40 mL). After drying over Na2SO4 and evaporation the two main products were
separated on a silica gel column. In most cases, subsequent purification on preparative TLC
(Merck, Kieselgel 60, eluent n-hexane:acetone 7:3) was necessary to obtain the pure red
products 7 (25 mg, 41%) and 8 (19 mg, 22%).
Capsanthin tetra-O-acetyl-β-D-glucoside (7): UV (λmax nm, EtOH): 476; IR (KBr pellet, cm-
1): 3319 m, 1726 vs (νCO, acetate), 1695 vs (conjugated νCO), 1616 s (νC=C), 1246, 1110 vs
(νC-O-C). MS (MALDI-TOF) m/z = 937.5 (M+Na). 1H-NMR (500 MHz, CDCl3) δ ppm: 0.84
(3H, s, 16'-Me), 1.08 (6H, s, 16,17-Me), 1.21 (3H, s, 17'-Me), 1.37 (3H, s, 18'-Me), 1.74 (3H,
s, 18-Me), 1.96-2.2 (30H, m, 19-Me, 19'-Me, 20-Me, 20'-Me, 2-H, 2'-H, acetyl-Me), 2.35
(1H, dd, J=17 Hz, 6, 4α-H), 3.01 (1H, dd, J=15.5 Hz, 9, 4'α-H), 3.99 (1H, m, 3-H), 4.37 (1H,
m, 3'-H), 4.23 (2H, m, 6''-H), 4.95 (1H, d, J=10 Hz, 4''-H), 5.20-5.32 (3H, m, 2''-H, 3''-H, 5''-
H), 5.74 (1H, d, J=6.0 Hz, 1''-H), 6.13 (2H, s, 7-H, 8-H), 6.16-6.75 (11H, m, olefin-Hs), 7.36
(1H, d, J=14 Hz, 8'-H). 13C-NMR (125 MHz, CDCl3): 12.7-12.85 (m), 21.5, 21.7, 25.1, 25.6,
28.6, 29.9, 37.0 (1-C), 40.8 (4-C), 43.4 (1'-C), 46.5 (4'-C), 49.0 (2-C), 50.6 (2'-C), 58.5 (5'-C),
63.2, 66.7 (3-C), 69.4, 71.9, 73.2, 73.8, 74.3, 96.9 (1''-C), 120.8, 125.9, 126.2, 129.8, 131.3,